Minibeam Radiation Therapy Treatment (MBRT): Commissioning and First Clinical Implementation

Michael P. Grams, Chrystian Quintero Mateus, Maryam Mashayekhi, Robert W. Mutter, Valentin Djonov, Jennifer M. Fazzari, Huaping Xiao, Kelsey M. Frechette, Adam J. Wentworth, Jonathan M. Morris, Brandon Klebel, Jack C. Thull, Rachael M. Guenzel, David J.Schembri Wismayer, Fabrice Lucien, Sean S. Park, Scott C. Lester

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Minibeam radiation therapy (MBRT) is characterized by the delivery of submillimeter-wide regions of high “peak” and low “valley” doses throughout a tumor. Preclinical studies have long shown the promise of this technique, and we report here the first clinical implementation of MBRT. Methods and Materials: A clinical orthovoltage unit was commissioned for MBRT patient treatments using 3-, 4-, 5-, 8-, and 10-cm diameter cones. The 180 kVp output was spatially separated into minibeams using a tungsten collimator with 0.5 mm wide slits spaced 1.1 mm on center. Percentage depth dose (PDD) measurements were obtained using film dosimetry and plastic water for both peak and valley doses. PDDs were measured on the central axis for offsets of 0, 0.5, and 1 cm. The peak-to-valley ratio was calculated at each depth for all cones and offsets. To mitigate the effects of patient motion on delivered dose, patient-specific 3-dimensional-printed collimator holders were created. These conformed to the unique anatomy of each patient and affixed the tungsten collimator directly to the body. Two patients were treated with MBRT; both received 2 fractions. Results: Peak PDDs decreased gradually with depth. Valley PDDs initially increased slightly with depth, then decreased gradually beyond 2 cm. The peak-to-valley ratios were highest at the surface for smaller cone sizes and offsets. In vivo film dosimetry confirmed a distinct delineation of peak and valley doses in both patients treated with MBRT with no dose blurring. Both patients experienced prompt improvement in symptoms and tumor response. Conclusions: We report commissioning results, treatment processes, and the first 2 patients treated with MBRT using a clinical orthovoltage unit. While demonstrating the feasibility of this approach is a crucial first step toward wider translation, clinical trials are needed to further establish safety and efficacy.

Original languageEnglish (US)
Pages (from-to)1423-1434
Number of pages12
JournalInternational Journal of Radiation Oncology Biology Physics
Volume120
Issue number5
DOIs
StatePublished - Dec 1 2024

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Minibeam Radiation Therapy Treatment (MBRT): Commissioning and First Clinical Implementation'. Together they form a unique fingerprint.

Cite this